Посещаемость сайта свыше 2000 человек в сутки (статистика). Среди более 28000 наших врачей-подписчиков более 2000 докторов и кандидатов медицинских наук, лидеры научных школ и руководители здравоохранения.Издание распространяется бесплатно, для использования профессиональных и интерактивных материалов необходима регистрация
Дерматология в России выходит и обновляется практически ежедневно. Сайт предоставляет возможности коммуникации для практикующих врачей, ученых, преподавателей, представителей общественных организаций и фармацевтической индустрии
14:00-15:30 | Plenary session : Best of new aspects in the field of... Sponsored by Roche Chairs: Jean-Jacques Grob (France), Claus Garbe (Germany), Bernard Guillot (France)
Therapeutically relevant targets of cutaneous tumors Hensin Tsao (USA)
Take home messagesAxel Hauschild (Germany)
15:30-16:00 | Coffee break
16:00-17:30 | Free oral commnunication Chairs: Alexander Stratigos (Greece), Colin Fleming (Scotland), Laurent Misery (France)
17:30-18:30 | Opening Ceremony
18:30-20:00 | Satellite symposium MSD/Schering-Plough: Selecting patients for adjuvant treatment for melanoma
Tuesday, 21 June 2011
08:30-10:00 | Plenary session: Primary prevention and early detection of melanoma: hot topics today Chairs: Luc Thomas (France), Hubert Pehamberger (Austria), Michael Binder (Austria)
EPIDERM: Results of an EU-project against skin cancer
Eggert Stockfleth (Germany)
Sunbed and melanoma risk: myth or reality? Isabel Longo (Spain)
Euromelanoma: results of a pan European skin cancer prevention campaign Véronique Del Marmol (Belgium)
Photo protection, vitamin D: where we are today? Marjam Barysch (Switzerland)
Follow up strategies for Nevi: is it still of interest? Jean-Jacques Grob (France)
New concepts in nevogenesis
Iris Zalaudek (Austria)
Take home messagesKetty Peris (Italy)
10:00-10:30 | Coffee break
10:30-11:00 | Guest Lecture Chairs: Georg Weinlich (Austria), Isabel Longo (Spain)
Genetic bases of human pigmentation: hope for new treatments? Richard A. Sturm (Australia)
11:00-12:30 | Plenary session: Melanoma management Sponsored by MSD/Schering-Plough
Chairs: Josep Malvehy (Spain), Caroline Robert (France), Axel Hauschild (Germany)
Next staging classification?
Jeffrey Gershenwald (United States)
New standards of pathology reporting
Alain Spatz (Canada)
Biomarkers of interferon responsiveness useful in routine
Helen Gogas (Greece)
Prognostic factors for sentinel lymph nodes and adjuvant treatment Vernon Sondak (United States)
An evidence based approach to excision margins of melanoma
Philippe Saiag (France)
14:00-15:30 | Free oral commnunications Chairs: Alain Spatz (Canada), Peter Arenberger (Czech Republic), Marie-Françoise Avril (France)
15:30-16:00 | Coffee break
16:00-17:00 | Plenary session: Ongoing clinical trials Chairs: Jerry Marsden (United Kingdom), Peter Hersey (Australia), Brigitte Dréno (France)
Melanoma Axel Hauschild (Germany)
Lymphoma Robert Knobler (Austria)
Non melanoma skin cancer Céleste Lebbé (France)
Take home messages John Kirkwood (United States)
17:00-18:30 | Satellite symposium Roche: Advances in Skin Cancer - Finding a Tailored Solution for Patients
Wednesday, 22 June 2011
08:30-10:00 | Plenary session: Targeted therapy in melanoma: present and future
Chairs: Roland Kauffman (Germany), Helen Gogas (Greece), Philippe Saiag (France)
Monoclonal antibodies in melanoma John Kirkwood (United States)
Antigen specific immunotherapy Brigitte Dréno (France)
Targeted therapy Peter Hersey (Australia)
Anti angiogenic factors Hubert Pehamberger (Austria)
Cutaneous side effects and new drugs: how to manage? Caroline Robert (France)
Innate Immunity and melanoma: current status and perspective Georg Stingl (Austria)
11:00-12:30 | Plenary session: Melanoma: from basic research to practice Chairs: Céleste Lebbé (France), Reinhard Dummer (Switzerland), Dirk Schadendorf (Germany)
Outstanding questions in immunotherapy of melanoma Nathalie Labarrière (France)
Cells cultures and animal models in melanoma: new perspectives Jürgen Becker (Germany)
Human T cells responses against melanoma Pierre Coulie (Belgium)
Melanoma Genetic Julia Newton-Bishop (United-Kingdom)
Melanoma stem cell: still more questions than answers Lionel Larue (France)